Development and Validation of RP-HPLC Method for Estimation of Ticagrelor in Pharmaceutical Dosage Form and Force degradation study

Journal Title: International Journal of Experimental Research and Review - Year 2024, Vol 42, Issue 6

Abstract

Ticagrelor is a selective Adenosine diphosphate (ADP)-receptor antagonist which is prescribed in the form of tablets and acts as an oral antiplatelet for the prevention of further thrombotic events in patients with Acute coronary syndrome (ACS) and those undergoing Percutaneous coronary intervention (PCI). Therefore, accurate and reliable determination of Ticagrelor in bulk and in dosage forms is vital for clinical consideration. The objective of the method is to develop a new, simple, sensitive, accurate, and economical analytical method for the determination of assay of Ticagrelor Tablet and to perform a forced degradation study of Ticagrelor Tablet by RP-HPLC. Chromatographic separation was achieved on an UHPLC equipped with reverse phase C-18 (250 × 4.6mm, 5µ) with a mobile phase composed of acetonitrile and buffer solution (75:25) at a flow rate of 1.10 ml/min. The effluents were detected at a wavelength of 256 nm. The retention time of Ticagrelor was found to be at 3.579 min. The correlation coefficient for Ticagrelor was found to be 0.997. Recovery of Ticagrelor in the formulation was found to be 98%-102%. LOD and LOQ values of Ticagrelor were found to be 1.31 and 3.98, respectively. The method was proven to be precise (%RSD=2%), accurate (>90%), and specific for the measurement of Ticagrelor in tablets. Thus, being simple, accurate, precise, and rapid, the newly developed RP-HPLC method is recommended for the estimation of Ticagrelor in nature. Due to its high sensitivity and specificity, it is a suitable choice for identifying Ticagrelor in drugs and other products and differentiating hid similarities. However, this method can effectively be used for routine assay and stability study, which can help manage cardiovascular diseases since the quality and efficacy of Ticagrelor-containing products are significant to patients’ condition.

Authors and Affiliations

Suhas S. Siddheshwar, Ajay R. Borhade, Someshwar D. Mankar, Santosh B. Dighe , Arshu P. Patel

Keywords

Related Articles

Apoptosis and Autophagy: Therapeutic Implications in Cancer

Despite the advances in the medical field so far, cancer remains a global health priority even now. Considering the drug resistance and the failure of cancer therapies to achieve complete eradication of cancer cells in c...

Monkeypox Detection Using Hyper-Parameter Tuned Based Transferable CNN Model

The reemergence of Monkeypox, a communicable illness resulting from the Monkeypox virus, has raised apprehensions about a potential swift global pandemic similar to the COVID-19 epidemic as COVID-19 infections diminish g...

Examining a generic streaming architecture for smart manufacturing's Big data processing in Anomaly detection: A review and a proposal

The smart manufacturing industry has witnessed a rapid increase in data generation due to the integration of sensors, IoT devices, and other advanced technologies. With this huge amount of data, the need for efficient da...

An investigation of lead in urban environment of Kolkata city, India

The lead heavy metal is an important environmental pollutant particularly in the urban areas with high anthropogenic pressure like vehicular and industrial. Its presence in the atmosphere, soil, water and biological syst...

Comparison between Task-Oriented Training and Proprioceptive Neuromuscular Facilitation Exercise on Upper Extremity Function in Spastic Cerebral Palsy

This research investigates and compares the impacts of task-oriented training and proprioceptive neuromuscular facilitation (PNF) on the motor function of the affected arm in children diagnosed with spastic cerebral pals...

Download PDF file
  • EP ID EP743583
  • DOI 10.52756/ijerr.2024.v42.003
  • Views 23
  • Downloads 0

How To Cite

Suhas S. Siddheshwar, Ajay R. Borhade, Someshwar D. Mankar, Santosh B. Dighe, Arshu P. Patel (2024). Development and Validation of RP-HPLC Method for Estimation of Ticagrelor in Pharmaceutical Dosage Form and Force degradation study. International Journal of Experimental Research and Review, 42(6), -. https://europub.co.uk/articles/-A-743583